X4 Pharmaceuticals (XFOR) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to -$1.8 million.
- X4 Pharmaceuticals' Other Gross PP&E Adjustments rose 1217.22% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 million, marking a year-over-year increase of 1217.22%. This contributed to the annual value of -$1.4 million for FY2024, which is 5782.11% up from last year.
- As of Q3 2025, X4 Pharmaceuticals' Other Gross PP&E Adjustments stood at -$1.8 million, which was up 1217.22% from -$1.2 million recorded in Q2 2025.
- In the past 5 years, X4 Pharmaceuticals' Other Gross PP&E Adjustments registered a high of -$1.2 million during Q2 2025, and its lowest value of -$7.6 million during Q1 2021.
- Over the past 5 years, X4 Pharmaceuticals' median Other Gross PP&E Adjustments value was -$4.1 million (recorded in 2023), while the average stood at -$4.2 million.
- In the last 5 years, X4 Pharmaceuticals' Other Gross PP&E Adjustments plummeted by 73733.96% in 2021 and then surged by 5782.11% in 2024.
- Quarter analysis of 5 years shows X4 Pharmaceuticals' Other Gross PP&E Adjustments stood at -$6.5 million in 2021, then rose by 24.34% to -$4.9 million in 2022, then surged by 32.9% to -$3.3 million in 2023, then skyrocketed by 57.82% to -$1.4 million in 2024, then dropped by 28.07% to -$1.8 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$1.8 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$1.5 million for Q1 2025.